Fingerprint
Dive into the research topics where Julia johanna Almer Bromann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Komplet remission af metastatisk duodenal cancer efter behandling med BRAF-hæmmer
Hansen, H. B., Bromann, J. A., Høgdall, D., Schou, J. H. V. & Eefsen, R., 26 Jan 2026, In: Ugeskrift for Laeger. 188, 5, V08250650.Translated title of the contribution :Remission of metastatic duodenal cancer after treatment with BRAF inhibitor Research output: Contribution to journal › Journal article › Research › peer-review
-
Molecularly redefining small bowel adenocarcinoma to accelerate precision patient care - protocol of a multicenter observational cohort biomarker study
Døssing, R. H., Broman, J. J. A., O'Rourke, C. J., Tabaksblat, E. M., Andersen, J. B., Hansen, C. P., Poulsen, T. S., Høgdall, E. V. S., Schou, J. H. V. & Høgdall, D., 7 Jan 2025, In: BMC Cancer. 25, 1, 22.Research output: Contribution to journal › Journal article › Research › peer-review
-
Personalized Neoadjuvant Chemotherapy for Gastrointestinal Cancers: Shaping Imprecision to be Precise
Høgdall, D., Schou, J. V., Bromann, J. J. A., Andersen, J. B. & O’rourke, C. J., 13 Jun 2025, In: Clinical Cancer Research. 31, 12, p. 2309-2316 8 p.Research output: Contribution to journal › Review › peer-review
1 Citation (Scopus) -
The value of MMR characterization and efficacy of checkpoint inhibitor in patients with small-bowel adenocarcinomas: a retrospective real-world cohort study
Døssing, R. H., Bromann, J. J. A., Seierøe, K., Høgdall, E. V. S., Poulsen, T. S., Schou, J. H. V. & Hoegdall, D. T. S., 2025, In: ESMO Rare Cancers. 4, C, 100030.Research output: Contribution to journal › Journal article › Research › peer-review